As of April 16, 2025, Immunocore (IMCR) has a market cap of $1.35 billion USD. According to our data, Immunocore is ranked No.4587 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $1.35 B |
-8.70%
|
Dec 31, 2024 | $1.48 B |
-56.82%
|
Dec 29, 2023 | $3.42 B |
19.71%
|
Dec 30, 2022 | $2.86 B |
66.68%
|
Dec 31, 2021 | $1.71 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Adaptimmune Therapeutics
ADAP
|
$64.18 M |
-0.000 M
|
![]() UK
|
![]() bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
![]() USA
|
![]() Fate Therapeutics
FATE
|
$0.13 B |
0.000 M
|
![]() USA
|
![]() Iovance Biotherapeutics
IOVA
|
$1.06 B |
-0.000 M
|
![]() USA
|
![]() Legend Biotech
LEGN
|
$6.20 B |
-0.000 M
|
![]() USA
|
![]() MacroGenics
MGNX
|
$79.49 M |
-0.000 M
|
![]() USA
|
![]() Moderna
MRNA
|
$10.14 B |
-0.001 M
|
![]() USA
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.17 B |
0.000 M
|
![]() USA
|
Market Cap | = | IMCR Stock Price | * | IMCR Shares Outstanding |
= | $27.31 | * | 49.35 M | |
= | $1.35 B |